Transitions in vascular ultrasonography findings of temporal arteritis in a GCA case with progressive temporal headache and visual impairment.

Giant cell arteritis case report glucocorticoids rheumatology ultrasonography

Journal

Modern rheumatology case reports
ISSN: 2472-5625
Titre abrégé: Mod Rheumatol Case Rep
Pays: England
ID NLM: 101761026

Informations de publication

Date de publication:
11 Aug 2023
Historique:
received: 17 04 2023
revised: 06 07 2023
accepted: 29 07 2023
medline: 13 8 2023
pubmed: 13 8 2023
entrez: 12 8 2023
Statut: aheadofprint

Résumé

The European League Against Rheumatism and the American College of Rheumatology have stated that the halo sign on vascular ultrasonography (v-US) is relevant in diagnosing giant cell arteritis (GCA) and is equivalent to temporal artery biopsy. However, there are only a few reports about transitions in v-US findings after glucocorticoid (GC) therapy. We report the transitions in the v-US findings in a case of GCA after GC therapy. The patient had rapidly progressive symptoms, and there were concerns about blindness. After GC therapy, we first observed improvement in headache and visual impairment symptoms within 1 week, followed by rapid improvement in laboratory findings within 2 weeks. Subsequently, there were improvements in v-US findings after more than 2 months. In conclusion, these findings showed a dissociation between improvements in clinical symptoms and v-US findings of the temporal artery. Additionally, this case suggests that regular examination of v-US findings is useful in evaluating GCA with evident vascular wall thickness before GC therapy.

Identifiants

pubmed: 37572090
pii: 7241424
doi: 10.1093/mrcr/rxad046
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Japan College of Rheumatology 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Toshio Kawamoto (T)

Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.

Michihiro Ogasawara (M)

Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.

Go Murayama (G)

Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.

Yuko Matsuki-Muramoto (Y)

Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.

Eri Hayashi (E)

Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.

Mariko Harada (M)

Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.

Makio Kusaoi (M)

Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.

Masakazu Matsushita (M)

Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.

Ken Yamaji (K)

Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.

Naoto Tamura (N)

Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.

Classifications MeSH